|
|
||||||||
|
|
|||||||||
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Duke University Hospital, Durham, North Carolina; and 2 Cardiac Imaging of Augusta, Augusta, Georgia
Correspondence: For correspondence or reprints contact: Danny A. Basso, CNMT, NCT, FSNMTS, Cardiac Imaging of Augusta, 818 St. Sebastian Way, Ste. 305, Augusta, GA 30901. E-mail: dbasso{at}knology.net
ABSTRACT
The object of this review is to provide information about 201Tl-thallous chloride in radionuclide myocardial perfusion imaging. This technique has experienced a recent resurgence because of the shortage of 99mTc. After reading this article, the technologist will be able to describe the properties and uptake mechanism of 201Tl, the procedure for myocardial perfusion imaging with this agent, and the advantages and disadvantages of thallium, compared with the technetium agents.
Key Words: myocardial perfusion; 201Tl-thallous chloride; SPECT; 99mTc-sestamibi; 99mTc-tetrofosmin
This article has been cited by other articles:
![]() |
G. M. Currie, H. Kiat, and J. M. Wheat Global Contrast in Nuclear Medicine J. Nucl. Med. Technol., September 1, 2010; 38(3): 115 - 116. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| THE JOURNAL OF NUCLEAR MEDICINE | JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY |